Gemmer Asset Management’s Medifast MED Stock Holding History

Gemmer Asset Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-59	Closed	-$10K	–	715
2022 Q1	$10K	Hold	59	–	–	﹤0.01%	706
2021 Q4	$12K	Hold	59	–	–	﹤0.01%	666
2021 Q3	$11K	Hold	59	–	–	﹤0.01%	668
2021 Q2	$17K	Hold	59	–	–	﹤0.01%	596
2021 Q1	$12K	Hold	59	–	–	﹤0.01%	697
2020 Q4	$12K	Hold	59	–	–	﹤0.01%	620
2020 Q3	$10K	Hold	59	–	–	﹤0.01%	614
2020 Q2	$8K	Buy	59 +27	+84%	+$2.48K	﹤0.01%	682
2020 Q1	$2K	Buy	+32	New	+$2.91K	﹤0.01%	1081
2019 Q4	–	Sell	-26	Closed	-$3K	–	1400
2019 Q3	$3K	Buy	+26	New	+$2.79K	﹤0.01%	1159

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NPIC

Neumeier Poma Investment Counsel Carmel, California $1.46B AUM 71.13% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Gemmer Asset Management's MED Position: Q2 2022 in Review

Gemmer Asset Management sold out of Medifast (MED) in Q2 2022, closing a stake of 59 shares — an estimated $10K sold.

Gemmer Asset Management first reported a position in MED in Q3 2019 and held it in 10 quarters. The position peaked at $17K in Q2 2021. 284 funds tracked by Wall St. Rank hold MED as of Q2 2022.

Gemmer Asset Management reported no remaining Medifast position as of Q2 2022 after selling out during the quarter.
Gemmer Asset Management sold 59 Medifast shares in Q2 2022, an estimated $10K.
Gemmer Asset Management first reported a position in Medifast in Q3 2019 and held it in 10 quarters.
Gemmer Asset Management's Medifast position peaked at $17K in Q2 2021.
284 funds tracked by Wall St. Rank held Medifast as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.